- Home
- PBPB vs PRQR Comparison
PBPB vs PRQR Comparison
Compare PBPB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBPB
- PRQR
- Stock Information
- Founded
- PBPB 1977
- PRQR 2012
- Country
- PBPB United States
- PRQR Netherlands
- Employees
- PBPB N/A
- PRQR N/A
- Industry
- PBPB Restaurants
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PBPB Consumer Discretionary
- PRQR Health Care
- Exchange
- PBPB Nasdaq
- PRQR Nasdaq
- Market Cap
- PBPB 313.6M
- PRQR 309.5M
- IPO Year
- PBPB 2013
- PRQR 2014
- Fundamental
- Price
- PBPB $9.40
- PRQR $2.67
- Analyst Decision
- PBPB Strong Buy
- PRQR Strong Buy
- Analyst Count
- PBPB 3
- PRQR 5
- Target Price
- PBPB $15.67
- PRQR $7.60
- AVG Volume (30 Days)
- PBPB 119.1K
- PRQR 605.4K
- Earning Date
- PBPB 11-07-2024
- PRQR 11-07-2024
- Dividend Yield
- PBPB N/A
- PRQR N/A
- EPS Growth
- PBPB 641.95
- PRQR N/A
- EPS
- PBPB 1.25
- PRQR N/A
- Revenue
- PBPB $471,719,000.00
- PRQR $20,506,357.00
- Revenue This Year
- PBPB N/A
- PRQR $235.11
- Revenue Next Year
- PBPB $3.71
- PRQR N/A
- P/E Ratio
- PBPB $7.52
- PRQR N/A
- Revenue Growth
- PBPB N/A
- PRQR 306.68
- 52 Week Low
- PBPB $6.28
- PRQR $1.61
- 52 Week High
- PBPB $14.36
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PBPB 46.87
- PRQR 38.02
- Support Level
- PBPB $8.98
- PRQR $2.48
- Resistance Level
- PBPB $10.19
- PRQR $2.71
- Average True Range (ATR)
- PBPB 0.34
- PRQR 0.29
- MACD
- PBPB -0.14
- PRQR -0.08
- Stochastic Oscillator
- PBPB 30.43
- PRQR 28.09
About PBPB Potbelly Corporation
Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.